KidneyIntelX

Renalytix AI adds new biomarkers to platform for tricky to diagnose CKD

By Mallory Hackett 02:27 pm April 15, 2021

Clinical diagnostic company Renalytix AI has expanded its partnership with the Joslin Diabetes Center to integrate new biomarkers for kidney disease discovered by the center's researchers into the company’s KidneyIntelX platform. KidneyIntelX is an in vitro diagnostic platform that assesses the risk of adverse kidney outcomes in patients with Type 2 diabetes and early-stage kidney disease. By...

Renalytix AI and AstraZeneca team up to improve chronic kidney disease outcomes

By Mallory Hackett 11:56 am August 21, 2020

Artificial intelligence-enabled in vitro diagnostics company Renalytix AI announced today a research partnership with AstraZeneca to develop and launch medical strategies for cardiovascular, renal and metabolic diseases. The first stage of the collaboration will use KidneyIntelX, an AI-enabled in vitro diagnostic platform that gathers patient data from electronic medical records to generate a...